Our findings in mice, along with published genetic associations studies [28, 29], implicating MARCH1 in metabolic disease, prompted us to test for an association between MARCH1 and type 2 diabetes in humans using GWAS datasets. This evidence concerns the gene MARCHF1 and metabolic disease.